The objective of this trial is to evaluate the safety and efficacy of Xyrem® in long term use.
The trial is an open-label safety and efficacy study of subjects with fibromyalgia who completed either study 06-008 or 06-009. Total duration is up to 40 weeks of trial participation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
560
flexible dosing
Number of Subjects Reporting Adverse Events
Number of subjects reporting adverse events.
Time frame: Treatment Period (38 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pinnacle Research Group, LLC
Anniston, Alabama, United States
Suncoast Internal Medicine Consultants
Auburn, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
Advanced Clinical Research Institute
Anaheim, California, United States
Orange County Clinical Trials
Anaheim, California, United States
Northern California Research
Carmichael, California, United States
Med Investigations Inc.
Fair Oaks, California, United States
Nerve Pro Research
Irvine, California, United States
Arroyo Medical Group, Inc.
Pismo Beach, California, United States
AppleMed Research
Miami, Florida, United States
...and 81 more locations